These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 15801857
1. Cationic chalcone antibiotics. Design, synthesis, and mechanism of action. Nielsen SF, Larsen M, Boesen T, Schønning K, Kromann H. J Med Chem; 2005 Apr 07; 48(7):2667-77. PubMed ID: 15801857 [Abstract] [Full Text] [Related]
2. Structure-activity relationship of antibacterial chalcones. Avila HP, Smânia Ede F, Monache FD, Smânia A. Bioorg Med Chem; 2008 Nov 15; 16(22):9790-4. PubMed ID: 18951808 [Abstract] [Full Text] [Related]
3. Synthesis, biological evaluation, mechanism of action and quantitative structure-activity relationship studies of chalcones as antibacterial agents. Sivakumar PM, Priya S, Doble M. Chem Biol Drug Des; 2009 Apr 15; 73(4):403-15. PubMed ID: 19291103 [Abstract] [Full Text] [Related]
5. Synthesis, SAR and antibacterial studies on novel chalcone oxazolidinone hybrids. Selvakumar N, Kumar GS, Azhagan AM, Rajulu GG, Sharma S, Kumar MS, Das J, Iqbal J, Trehan S. Eur J Med Chem; 2007 Apr 15; 42(4):538-43. PubMed ID: 17150281 [Abstract] [Full Text] [Related]
6. Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus. Lv J, Qian Y, Liu T, Wang Y. Bioorg Med Chem Lett; 2007 Aug 01; 17(15):4102-6. PubMed ID: 17570664 [Abstract] [Full Text] [Related]
7. Antibacterial chalcones--bioisosteric replacement of the 4'-hydroxy group. Nielsen SF, Boesen T, Larsen M, Schønning K, Kromann H. Bioorg Med Chem; 2004 Jun 01; 12(11):3047-54. PubMed ID: 15142563 [Abstract] [Full Text] [Related]
8. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety. Emami S, Foroumadi A, Faramarzi MA, Samadi N. Arch Pharm (Weinheim); 2008 Jan 01; 341(1):42-8. PubMed ID: 18072241 [Abstract] [Full Text] [Related]
9. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Namba K, Zheng X, Motoshima K, Kobayashi H, Tai A, Takahashi E, Sasaki K, Okamoto K, Kakuta H. Bioorg Med Chem; 2008 Jun 01; 16(11):6131-44. PubMed ID: 18468909 [Abstract] [Full Text] [Related]
10. Novel chalcones and 1,3,5-triphenyl-2-pyrazoline derivatives as antibacterial agents. Sivakumar PM, Ganesan S, Veluchamy P, Doble M. Chem Biol Drug Des; 2010 Nov 01; 76(5):407-11. PubMed ID: 20925692 [Abstract] [Full Text] [Related]
11. Functionalized chalcones with basic functionalities have antibacterial activity against drug sensitive Staphylococcus aureus. Liu XL, Xu YJ, Go ML. Eur J Med Chem; 2008 Aug 01; 43(8):1681-7. PubMed ID: 18031869 [Abstract] [Full Text] [Related]
12. Antibacterial activity of flavonoids against methicillin-resistant Staphylococcus aureus strains. Alcaráz LE, Blanco SE, Puig ON, Tomás F, Ferretti FH. J Theor Biol; 2000 Jul 21; 205(2):231-40. PubMed ID: 10873434 [Abstract] [Full Text] [Related]
13. Bulky nonproteinogenic amino acids permit the design of very small and effective cationic antibacterial peptides. Haug BE, Stensen W, Stiberg T, Svendsen JS. J Med Chem; 2004 Aug 12; 47(17):4159-62. PubMed ID: 15293987 [Abstract] [Full Text] [Related]
14. Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety. Tomar V, Bhattacharjee G, Kamaluddin, Kumar A. Bioorg Med Chem Lett; 2007 Oct 01; 17(19):5321-4. PubMed ID: 17719779 [Abstract] [Full Text] [Related]
15. Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted. Batovska D, Parushev S, Stamboliyska B, Tsvetkova I, Ninova M, Najdenski H. Eur J Med Chem; 2009 May 01; 44(5):2211-8. PubMed ID: 18584918 [Abstract] [Full Text] [Related]
16. Synthesis and antibacterial evaluation of novel 4-alkyl substituted phenyl beta-aldehyde ketone derivatives. Liu J, Cao R, Wu Q, Ma C, Wang Z, Peng W, Song H. Eur J Med Chem; 2009 Apr 01; 44(4):1737-44. PubMed ID: 18450331 [Abstract] [Full Text] [Related]
17. Design, synthesis and antibacterial activity of chalcones against MSSA and MRSA planktonic cells and biofilms. Garcia MAR, Theodoro RS, Sardi JCO, Santos MB, Ayusso GM, Pavan FR, Costa AR, Santa Cruz LM, Rosalen PL, Regasini LO. Bioorg Chem; 2021 Nov 01; 116():105279. PubMed ID: 34509799 [Abstract] [Full Text] [Related]
18. Marine lipids as building blocks for soft quaternary ammonium compounds and their antibacterial activity. Loftsson T, Thorsteinsson T, Másson M. Pharmazie; 2004 May 01; 59(5):360-4. PubMed ID: 15212301 [Abstract] [Full Text] [Related]
19. Molecular design of anti-MRSA agents based on the anacardic acid scaffold. Green IR, Tocoli FE, Lee SH, Nihei K, Kubo I. Bioorg Med Chem; 2007 Sep 15; 15(18):6236-41. PubMed ID: 17601740 [Abstract] [Full Text] [Related]
20. Design, synthesis, and structure-activity relationships of benzophenone-based tetraamides as novel antibacterial agents. Vooturi SK, Cheung CM, Rybak MJ, Firestine SM. J Med Chem; 2009 Aug 27; 52(16):5020-31. PubMed ID: 19653650 [Abstract] [Full Text] [Related] Page: [Next] [New Search]